Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)

Subscribe to Selected New Research on Pelvic Inflammatory Disease

1079 relevant articles (64 outcomes, 126 trials/studies) found for this Disease

Description: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.

Also Known As:

Pelvic Inflammatory Diseases; Inflammatory Disease, Pelvic; Inflammatory Pelvic Disease; Pelvic Disease, Inflammatory; Disease, Inflammatory Pelvic; Disease, Pelvic Inflammatory; Diseases, Inflammatory Pelvic; Diseases, Pelvic Inflammatory; Inflammatory Diseases, Pelvic; Inflammatory Pelvic Diseases; Pelvic Diseases, Inflammatory; Adnexitis

Relationship Network

Disease Context: Research Results

Bacterial Infections and Mycoses

Infection: 225242

Pelvic Infection: 383

Pelvic Inflammatory Disease: 1079

Female Urogenital Diseases and Pregnancy Complications

Female Urogenital Diseases

Female Genital Diseases: 189

Adnexal Diseases: 36

Pelvic Inflammatory Disease: 1079

Related Diseases

1.	Infection
2.	Ovarian Neoplasms (Ovarian Cancer)
3.	Endometrial Neoplasms (Endometrial Cancer)
4.	Breast Diseases (Breast Disease)
5.	Abscess

Experts

1.	Bass, Debra C: 3 articles (02/2008 - 05/2004)
2.	Ness, Roberta B: 3 articles (02/2008 - 05/2004)
3.	Schubeck, Diane: 2 articles (02/2008 - 08/2004)
4.	Richter, Holly E: 2 articles (02/2008 - 08/2004)
5.	Brunham, Robert C: 2 articles (02/2008 - 05/2004)
6.	Randall, Hugh: 2 articles (02/2008 - 08/2004)
7.	Peipert, Jeffrey F: 2 articles (02/2008 - 08/2004)
8.	Soper, David E: 2 articles (02/2008 - 08/2004)
9.	Nelson, Deborah B: 2 articles (02/2008 - 08/2004)
10.	Berglund, L: 2 articles (01/2006 - 12/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Pelvic Inflammatory Disease:

1.	Anti-Bacterial Agents (Antibiotics)IBA 01/01/2007 - "[Efficacy of intraosseous administration of antibiotics in the treatment of pelvic inflammatory diseases in women]" 08/15/1987 - "Efficacy of different antibiotics in the treatment of pelvic inflammatory disease." 07/01/1986 - "A follow-up study was undertaken in 493 women who had participated in a clinical, controlled trial with the object of assessing the role of postabortal pelvic inflammatory disease and prophylactic antibiotics in the development of sequelae. " 04/01/2008 - "A pelvic inflammatory disease due to a genital Chlamydia trachomatis was highly suspected and she was treated with targeted antibiotics. " 01/01/2007 - "The results of complex therapy of 87 young women with severe acute pelvic inflammatory diseases by intraosseous administration of antibiotics were analysed. " Order ALL the reference details at left...
2.	Clindamycin (Cleocin)FDA LinkGeneric 09/01/1992 - "It also can be administered in combination with a drug such as clindamycin for treatment of pelvic inflammatory disease or postoperative pelvic infections." 01/03/1981 - "Patients with endometritis or adnexitis usually received clindamycin in combination with an aminopenicillin. " 02/01/1986 - "Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin." 02/01/1990 - "The results suggest that intravenous clindamycin alone is a viable alternative to the use of clindamycin/tobramycin for women with acute pelvic inflammatory disease requiring hospitalization." 02/01/1990 - "Comparative evaluation of clindamycin versus clindamycin plus tobramycin in the treatment of acute pelvic inflammatory disease." Order ALL the reference details at left...
3.	Doxycycline (Vibramycin)FDA LinkGeneric 11/15/1983 - "Prevention of acute pelvic inflammatory disease after hysterosalpingography: efficacy of doxycycline prophylaxis." 10/01/1994 - "Two double-blind randomized studies conducted in Africa comparing a 200 mg prophylactic dose of doxycycline with a placebo did not conclusively identify a reduced risk of post-insertion pelvic inflammatory disease (PID). " 12/01/2002 - "In this case report, a 33 year old female patient who had been prescribed doxycycline for pelvic inflammatory disease is presented. " 11/01/1994 - "Women discharged from a municipal emergency department with the diagnosis of pelvic inflammatory disease were surveyed by telephone about their compliance with a standard 10-day regimen of doxycycline. " 11/01/1994 - "Compliance with doxycycline therapy for outpatient treatment of pelvic inflammatory disease." Order ALL the reference details at left...
4.	Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric 04/01/1988 - "This study suggests that the combination of cefoxitin and doxycycline is effective for ambulatory treatment of pelvic inflammatory disease." 10/29/1983 - "Efficacy of ampicillin and cefoxitin in the treatment of acute pelvic inflammatory disease. " 10/01/2008 - "Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease." 02/01/2008 - "genitalium has been associated with treatment failure following cefoxitin and doxycycline treatment for clinically suspected pelvic inflammatory disease. " 01/01/1997 - "Ampicillin/Sulbactam vs. Cefoxitin for the treatment of pelvic inflammatory disease." Order ALL the reference details at left...
5.	Oral ContraceptivesIBA 01/05/1990 - "Studies have shown that oral contraceptive use may protect against pelvic inflammatory disease (PID), but it is not known whether oral contraceptives protect against the disease among women already infected with Chlamydia trachomatis or Neisseria gonorrhoeae. " 11/15/1982 - "To study the association of the use of oral contraceptives (OCs) and pelvic inflammatory disease (PID), the US Centers for Disease Control analyzed data from the Women's Health Study, a large multicenter case-control study of contraceptive use and serious gynecologic disorders; it included data from interviews of 648 women hospitalized with an initial episode of PID and 2516 hospitalized control subjects. " 12/01/2001 - "As with oral contraceptives, the risk of pelvic inflammatory disease is reduced, because of reduced menstrual blood loss, endometrial suppression, and thickening of the cervical mucus. " 01/01/1991 - "A case-control analysis of hospital-based data was conducted to evaluate whether low-dose combination oral contraceptives (OCs) protect against pelvic inflammatory disease (PID). " 02/01/1985 - "Gonococcal pelvic inflammatory disease, oral contraceptives, and cervical mucus." Order ALL the reference details at left...
6.	Ampicillin (Omnipen)FDA LinkGeneric 01/01/1989 - "This report concerns the prospective evaluation of the efficacy of the combination of sulbactam with ampicillin in patients hospitalized with acute pelvic inflammatory disease. " 10/29/1983 - "Efficacy of ampicillin and cefoxitin in the treatment of acute pelvic inflammatory disease. " 01/01/1989 - "Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease." 04/17/1987 - "Combination treatment is more than twice as cost-effective as tetracycline and seven times as cost-effective as ampicillin when the medical cost of managing pelvic inflammatory disease is considered. " 10/01/1986 - "Comparison of preventive use of metronidazole and ampicillin in women with a history of pelvic inflammatory disease undergoing first-trimester abortion." Order ALL the reference details at left...
7.	Ciprofloxacin (Cipro)FDA LinkGeneric 01/01/1988 - "Oral ciprofloxacin-monotherapy proved to be safe and effective in pelvic inflammatory disease." 01/01/1988 - "The study showed clinical efficacy of orally administered ciprofloxacin in pelvic inflammatory disease." 11/30/1989 - "Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin." 08/01/2008 - "Pelvic inflammatory disease with Tc-99m ciprofloxacin imaging." 10/01/2000 - "Imaging pelvic inflammatory disease with Tc-99m ciprofloxacin." Order ALL the reference details at left...
8.	Ofloxacin (Levofloxacin)FDA LinkGeneric 01/01/1995 - "Ofloxacin appears to be effective therapy for pelvic inflammatory disease, without the need for additional anaerobe cover. " 01/01/1999 - "OBJECTIVE: To evaluate the safety and efficacy of intravenous and oral ofloxacin monotherapy in the treatment of laparoscopically documented acute pelvic inflammatory disease (PID). " 10/01/1993 - "In a double-blind stratificated, placebo controlled study the efficacy and safety of a single oral dose of ofloxanin (Tarivid) (400 mg) in preventing postabortal pelvic inflammatory disease (P-PID) in women with induced first-trimester abortions were assessed. " 09/01/2003 - "Psychiatric side effects of ofloxacin used in the treatment of pelvic inflammatory disease." 09/01/2006 - "Pancytopenia with levofloxacin therapy for pelvic inflammatory disease in an otherwise healthy young patient." Order ALL the reference details at left...
9.	Sulbactam FDA LinkGeneric 01/01/1989 - "This report concerns the prospective evaluation of the efficacy of the combination of sulbactam with ampicillin in patients hospitalized with acute pelvic inflammatory disease. " 01/01/1989 - "Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease." 01/01/1986 - "The sulbactam/ampicillin failure was a patient with pelvic inflammatory disease with a positive Chlamydia trachomatis culture who required antichlamydial therapy. " 01/01/1991 - "A total of 30 women with pelvic inflammatory disease, wound infections, vaginitis and puerperal sepsis received an intramuscular combination of sulbactam/ampicillin in a total daily dose of 1.5 g for between 3 and 7 days. " 06/01/1996 - "The clinical efficacy and safety of sulbactam/ampicillin has been emphasized by the results from a number of randomized trials, including studies in patients with community-acquired pneumonia, meningitis, endometritis and pelvic inflammatory disease, and diabetic foot infections. " Order ALL the reference details at left...
10.	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 07/01/1994 - "CONCLUSIONS: This study demonstrated a significant reduction in post-operative pelvic inflammatory disease in low risk patients, who were applying for legal first trimester abortion, treated peroperatively with ceftriaxone. " 03/01/1989 - "Additional studies are required for further elucidation of the role of ceftriaxone in the treatment of pelvic inflammatory disease and syphilis. " 07/01/1996 - "It was 90.26%, the therapeutic success in the treatment of pelvic inflammatory diseases by Ceftriaxon plus Doxycycline was noted in 90.19% of patients. " 03/01/1996 - "These included ceftriaxone, $8.60 per dose; cefixime, $4.67 per dose; ceftriaxone efficacy, 98% (range, 94.9% to 100%); cefixime efficacy, 97% (94.1% to 100%); and a 15% probability of pelvic inflammatory disease (PID) related to failed treatment. " 01/01/1993 - " Treatment involved administration of 250 mg ceftriaxone intramuscularly and oral doxycycline for pelvic inflammatory disease. " Order ALL the reference details at left...

Therapies and Procedures

1.	Intrauterine Devices (Intrauterine Device) 12/01/2005 - "OBJECTIVE: To study the microbial characteristics of patients with pelvic inflammatory disease (PID) and the possible impact of an intrauterine device (IUD) on the microbial environment in women presenting with PID. " 09/01/2001 - "Because we found that BV was associated with IUDs and that other studies reported that both BV and IUDs were associated with pelvic inflammatory disease, a Gram stain evaluation of BV may be considered prior to IUD insertion" 09/01/2000 - "Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990." 06/01/1998 - " In the IUD group, there was one expulsion during the study period, but no cases of perforation, pelvic inflammatory disease, or pregnancy. " 12/01/1996 - "In order to present an overview of current understanding about the relationship between pelvic inflammatory disease (PID) and IUD use, this paper reviews the evolution of pertinent studies and identifies study design limitations. " Order ALL the reference details at left...
2.	Contraception (Birth Control) 02/01/1991 - "This significantly lowered incidence of pelvic inflammatory disease may help to solve one of the major concerns associated with intrauterine contraception." 12/01/1996 - "Long-term clinical studies have suggested a protective effect on pelvic inflammatory disease, have demonstrated that it is highly acceptable to the majority of women requesting effective contraception, and have shown that it may be used at any time throughout the fertile period and beyond." 07/09/1982 - "The protective effect of barrier-method contraception against pelvic inflammatory disease (PID) was examined by analyzing data from the Women's Health Study, a large multicenter case-control study. " 10/01/2006 - "It is prudent that clinicians provide counseling regarding healthy sexual behaviors, STD prevention, and contraception whenever an adolescent presents in need of STD screening or evaluation for pelvic inflammatory disease." 01/01/2006 - "A causal relationship between intrauterine contraception and pelvic inflammatory disease was believed by 52.5%. " Order ALL the reference details at left...
3.	Hysterectomy 06/01/1993 - "The data on hysterectomy are particularly interesting; the operation in women with pelvic inflammatory disease is most often a consequence of the inflammatory process itself." 10/01/1987 - "Total abdominal hysterectomy was commonly performed due to the high rate of chronic pelvic inflammatory disease. " 02/01/1984 - "Extensive surgery for pelvic inflammatory disease was defined as hysterectomy or bilateral adenexal surgery, with pelvic inflammatory disease as the only gynecologic discharge diagnosis. " 01/01/1951 - "[Septicopyemia from Proteus after subtotal hysterectomy for chronic adnexitis.]" 01/01/1985 - "Total abdominal hysterectomy and bilateral salpingo-oophorectomy as a treatment for pelvic inflammatory disease should be the exception rather than the rule." Order ALL the reference details at left...
4.	Balneology 10/01/2008 - "CONCLUSIONS: As demonstrated by our results, 3-week balneotherapy is a potentially useful adjunct for the management of chronic pelvic inflammatory disease, but further, long-term studies are notwithstanding necessary." 01/01/1970 - "[Results of balneotherapy in cases of disturbed menstrual cycle in the course of adnexitis]" 07/01/1968 - "[Complementary balneotherapy after glucocorticotherapy of adnexitis in sterile women]" 05/01/1952 - "[Balneotherapy of chronic adnexitis.]" 06/01/1980 - "[Evaluation of the results of treatment of acute adnexitis with sulfonamides and antibiotics in the course of balneotherapy]" Order ALL the reference details at left...
5.	Laparotomy 01/01/2007 - "The patient was subjected for laparotomy with the preoperative diagnosis of chronic pelvic inflammatory disease. " 05/01/2006 - "Two and one-half months later the patient presented with signs and symptoms of pelvic inflammatory disease and underwent hospitalization and exploratory laparotomy. " 04/01/1994 - "To investigate the frequency of lumbosacral pains and sacroiliitis as late sequela of severe pelvic inflammatory disease (PID) confirmed by laparoscopy or laparotomy. " 04/01/1994 - "Reactive sacroiliitis as late sequela after severe pelvic inflammatory disease verified by laparoscopy or laparotomy." 01/01/1991 - " Of the 45 patients who were able to be examined 1-2 years after surgery, only 3 experienced recurrent pelvic inflammatory disease (8% of pelviscopically treated patients and 5% of laparotomy patients) which the physicians found encouraging since pregnancies may occur. " Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Pelvic Inflammatory Disease

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 64 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>